Therapeutic Efficacy of Differentiated Versus Undifferentiated Mesenchymal Stem Cells in Experimental Type I Diabetes in Rat

Overview

Journal Biochem Biophys Rep

Specialty Biochemistry

Date 2017 Sep 29

PMID 28955854

Citations 4

Authors

M A Wassef

H Fouad

D Sabry

N Afifi

A M Abbas

W Mostafa

S H Ahmed

Affiliations

Soon will be listed here.

Abstract

Selective MSCs differentiation protocol into pancreatic beta cells was conducted in the present study using exendin-4 and TGF-beta. Differentiated and undifferentiated MSCs were assessed in experimental type I diabetes in rats. Ninety female white albino rats were included in the study and divided equally (n=15/group) into 6 groups: healthy control, healthy control rats received acellular tissue culture medium, diabetic rats, diabetic rats received acellular tissue culture medium, diabetic rats received undifferentiated MSCs and diabetic rats received differentiated MSCs. Therapeutic efficacy of undifferentiated versus differentiated MSCs was evaluated via assessment of quantitative gene expressions of . Blood glucose and insulin hormone levels were also assessed. Results showed that quantitative gene expressions of all studied genes showed significant decrease in diabetic rat groups. Use of undifferentiated and differentiated MSCs led to a significant elevation of expression levels of all genes with more superior effect with differentiated MSCs except gene. As regards insulin hormone levels, use of either undifferentiated or differentiated MSCs led to a significant elevation of its levels with more therapeutic effect with differentiated MSCs. Blood glucose levels were significantly decreased with both undifferentiated and differentiated MSCs in comparison to diabetic groups but its levels were normalized 2 months after injection of differentiated MSCs. In conclusion, use of undifferentiated or differentiated MSCs exhibited significant therapeutic potentials in experimental type I diabetes in rats with more significant therapeutic effect with the use of differentiated MSCs.

Citing Articles

Substrate topographies modulate the secretory activity of human bone marrow mesenchymal stem cells.

Rosado-Galindo H, Domenech M Stem Cell Res Ther. 2023; 14(1):208.

PMID: 37605275 PMC: 10441765. DOI: 10.1186/s13287-023-03450-0.

Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis.

Li Y, Wang F, Liang H, Tang D, Huang M, Zhao J Stem Cell Res Ther. 2021; 12(1):273.

PMID: 33957998 PMC: 8101194. DOI: 10.1186/s13287-021-02342-5.

Tanshinone IIA and Astragaloside IV promote the angiogenesis of mesenchymal stem cell-derived endothelial cell-like cells via upregulation of , and .

Li Z, Zhang S, Cao L, Li W, Ye Y, Shi Z Exp Ther Med. 2018; 15(2):1847-1854.

PMID: 29434774 PMC: 5776521. DOI: 10.3892/etm.2017.5636.

Combination of Obestatin and Bone Marrow Mesenchymal Stem Cells Prevents Aggravation of Endocrine Pancreatic Damage in Type II Diabetic Rats.

Hussien N, Ebrahim N, Mohammed O, Sabry D Int J Stem Cells. 2017; 10(2):129-143.

PMID: 29186652 PMC: 5741194. DOI: 10.15283/ijsc17035.

References

Gasa R, Mrejen C, Lynn F, Skewes-Cox P, Sanchez L, Yang K . Induction of pancreatic islet cell differentiation by the neurogenin-neuroD cascade. Differentiation. 2007; 76(4):381-91. DOI: 10.1111/j.1432-0436.2007.00228.x. View

Yew K, Prasadan K, Preuett B, Hembree M, McFall C, Benjes C . Interplay of glucagon-like peptide-1 and transforming growth factor-beta signaling in insulin-positive differentiation of AR42J cells. Diabetes. 2004; 53(11):2824-35. DOI: 10.2337/diabetes.53.11.2824. View

Abdel Aziz M, Atta H, Mahfouz S, Fouad H, Roshdy N, Ahmed H . Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem. 2007; 40(12):893-9. DOI: 10.1016/j.clinbiochem.2007.04.017. View

Marappagounder D, Somasundaram I, Dorairaj S, Janavikula Sankaran R . Differentiation of mesenchymal stem cells derived from human bone marrow and subcutaneous adipose tissue into pancreatic islet-like clusters in vitro. Cell Mol Biol Lett. 2012; 18(1):75-88. PMC: 6275636. DOI: 10.2478/s11658-012-0040-5. View

Jian R, Mao L, Xu Y, Li X, Wang F, Luo X . Generation of insulin-producing cells from C3H10T1/2 mesenchymal progenitor cells. Gene. 2015; 562(1):107-16. DOI: 10.1016/j.gene.2015.02.061. View

Khorsandi L, Nejad-Dehbashi F, Ahangarpour A, Hashemitabar M . Three-dimensional differentiation of bone marrow-derived mesenchymal stem cells into insulin-producing cells. Tissue Cell. 2015; 47(1):66-72. DOI: 10.1016/j.tice.2014.11.005. View

Gabr M, Zakaria M, Refaie A, Khater S, Ashamallah S, Ismail A . Generation of insulin-producing cells from human bone marrow-derived mesenchymal stem cells: comparison of three differentiation protocols. Biomed Res Int. 2014; 2014:832736. PMC: 4000976. DOI: 10.1155/2014/832736. View

El-Gohary Y, Tulachan S, Wiersch J, Guo P, Welsh C, Prasadan K . A smad signaling network regulates islet cell proliferation. Diabetes. 2013; 63(1):224-36. PMC: 3868054. DOI: 10.2337/db13-0432. View

Seo M, Jeong Y, Park J, Park S, Rho K, Kim H . Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells. J Vet Sci. 2009; 10(3):181-7. PMC: 2801133. DOI: 10.4142/jvs.2009.10.3.181. View

10.

Bhonde R, Sheshadri P, Sharma S, Kumar A . Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. Int J Biochem Cell Biol. 2013; 46:90-102. DOI: 10.1016/j.biocel.2013.11.006. View

11.

Dave S . Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes. Adv Biomed Res. 2015; 3:266. PMC: 4298883. DOI: 10.4103/2277-9175.148247. View

12.

Jaiswal N, Haynesworth S, Caplan A, Bruder S . Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997; 64(2):295-312. View

13.

Zhou H, Li D, Shi C, Xin T, Yang J, Zhou Y . Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro. Sci Rep. 2015; 5:12898. PMC: 4528192. DOI: 10.1038/srep12898. View

14.

Vishwakarma S, Rahamathulla S, Bardia A, Tiwari S, Srinivas G, Raj A . In vitro quantitative and relative gene expression analysis of pancreatic transcription factors Pdx-1, Ngn-3, Isl-1, Pax-4, Pax-6 and Nkx-6.1 in trans-differentiated human hepatic progenitors. J Diabetes Investig. 2014; 5(5):492-500. PMC: 4188105. DOI: 10.1111/jdi.12193. View

15.

Ryan E, Paty B, Senior P, Bigam D, Alfadhli E, Kneteman N . Five-year follow-up after clinical islet transplantation. Diabetes. 2005; 54(7):2060-9. DOI: 10.2337/diabetes.54.7.2060. View

16.

Ren L, Chen L, Qi H, Li F, Gong F . In vitro differentiation of human adipose tissue-derived stem cells into islet-like clusters promoted by islet neogenesis-associated protein pentadecapeptide. Cells Tissues Organs. 2014; 199(5-6):329-41. DOI: 10.1159/000362500. View

17.

Abdel Aziz M, El-Asmar M, Haidara M, Atta H, Roshdy N, Rashed L . Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats. Med Sci Monit. 2008; 14(11):BR249-55. View

18.

Yew K, Hembree M, Prasadan K, Preuett B, McFall C, Benjes C . Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells. J Biol Chem. 2005; 280(37):32209-17. DOI: 10.1074/jbc.M505465200. View

19.

Calne R, Gan S, Lee K . Stem cell and gene therapies for diabetes mellitus. Nat Rev Endocrinol. 2010; 6(3):173-7. DOI: 10.1038/nrendo.2009.276. View

20.

Zaret K . Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat Rev Genet. 2008; 9(5):329-40. DOI: 10.1038/nrg2318. View